Alpha 2.0
Login Register
» Authors » F Couturaud

F Couturaud

Explore the profile of F Couturaud including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 366
Followers 0
Related Specialties
Pulmonary Medicine
Hematology
Cardiology & Vascular Diseases
Top 10 Co-Authors
C Leroyer
O Sanchez
D Mottier
L Bertoletti
P Girard
C Tromeur
I Mahe
S Laporte
F Parent
P Mismetti
Published In
Rev Mal Respir
Rev Pneumol Clin
Presse Med
Rev Med Interne
Thromb Haemost
Affiliations
Soon will be listed here.
Recent Articles
11.
Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
Suehs C, Zysman M, Chenivesse C, Burgel P, Couturaud F, Deslee G, et al.
BMJ Open . 2020 Jul; 10(7):e035811. PMID: 32611741
Objectives: Presently, those outcomes that should be prioritised for chronic obstructive pulmonary disease (COPD) exacerbation studies remain unclear. In order to coordinate multicentre studies on eosinophilia-driven corticosteroid therapy for patients...
12.
Venous thromboembolism and COVID-19
Bertoletti L, Couturaud F, Montani D, Parent F, Sanchez O
Respir Med Res . 2020 Jun; 78:100759. PMID: 32474397
No abstract available.
13.
[Diagnostic and therapeutic management of venous thromboembolic disease in obese patients]
Tromeur C, Le Mao R, Leven C, Couturaud F, Thereaux J, Lacut K
Rev Mal Respir . 2020 Apr; 37(4):328-340. PMID: 32284207
Despite the high proportion of obese patients this population remains understudied in the field of venous thromboembolic disease (VTE). Obesity is a risk factor for pulmonary embolism and/or deep vein...
14.
[Evolution of the costs and management of lung cancer between 2004 and 2014]
Gadby F, Descourt R, Robinet G, Quere G, Gouva S, Roge C, et al.
Rev Mal Respir . 2019 Dec; 37(1):1-7. PMID: 31862137
Background: Given its morbidity and mortality, lung cancer is a major public health issue. In recent years, it has benefited from several therapeutic innovations. The objective of this study was...
15.
[What duration of anticoagulant treatment for PE/proximal DVT?]
Couturaud F, Girard P, Laporte S, Sanchez O
Rev Mal Respir . 2019 Nov; 38 Suppl 1:e99-e112. PMID: 31711819
No abstract available.
16.
[What are the options for the initial anticoagulant treatment of a PE and a proximal DVT?]
Couturaud F, Fischer A, Laporte S, Sanchez O
Rev Mal Respir . 2019 Nov; 38 Suppl 1:e41-e52. PMID: 31699457
No abstract available.
17.
[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version]
Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, et al.
Rev Mal Respir . 2019 Jul; 38 Suppl 1:e1-e6. PMID: 31280989
No abstract available.
18.
Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutation
Ibrahim-Kosta M, Suchon P, Couturaud F, Smadja D, Olaso R, Germain M, et al.
Sci Rep . 2019 Mar; 9(1):3750. PMID: 30842582
Factor V serves an important role in the regulation of blood coagulation. The rs6025 (R534Q) and rs4524 (K858R) polymorphisms in the F5 gene, are known to influence the risk of...
19.
[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version]
Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, et al.
Rev Mal Respir . 2019 Feb; 36(2):249-283. PMID: 30799126
No abstract available.
20.
[Risk factors for thromboembolic disease in young women-the role of hormones]
Tromeur C, Le Mao R, Jego P, El-Kouri D, Gruel Y, Pan-Petesch B, et al.
Rev Mal Respir . 2018 Oct; 36(2):219-226. PMID: 30318429
Objective: To demonstrate an association between the risk of VTE in young women with hormonal exposure (pregnancy or oral contraceptive use) and the presence of a previous episode of VTE...